BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26917345)

  • 1. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.
    Daikoku T; Tannai H; Honda M; Onoe T; Matsuo K; Onoye Y; Nishizawa M; Kawana T; Okuda T; Hasegawa T; Shiraki K
    J Dermatol Sci; 2016 Jun; 82(3):160-5. PubMed ID: 26917345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
    Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
    Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
    J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Chibo D; Mijch A; Doherty R; Birch C
    J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
    Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
    PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
    Muller EE; Maseko DV; Kularatne RS
    Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.
    Sbidian E; Battistella M; Legoff J; Lafaurie M; Bézier M; Agbalika F; Simon F; Bouscarat F; Cayuela JM; Carcelain G; Houhou N; Bagot M; Molina JM; Janier M; Bachelez H
    Clin Infect Dis; 2013 Dec; 57(11):1648-55. PubMed ID: 24065320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
    Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
    Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
    Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.